Clinical Trial Update: Efficacy and Safety of Sintilimab Combined with Nab-PP Plus Rh-endostatin in Locally Advanced/advanced and Recurrent Metastatic Squamous Non-small Cell Lung Cancer: a Single-arm, Multicenter Clinical Study [Phase 2]

View source ↗

Summary

This Clinical Trial Update describes a Phase 2, single-arm multicenter study evaluating the combination of sintilimab with nab-paclitaxel and rh-endostatin in l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Non-small Cell Lung Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Endostar (recombinant human endostatin)
• Tyvyt (Sintilimab)

Snippet

Sponsor: Jian-Guo Zhou, MD, PhD | Conditions: Squamous Non-Small Cell Lung Cancer SqNSCLC | Phase 2 | Status: NOT_YET_RECRUITING